New-Born Screening


Screening in infants is done shortly after birth for conditions that are treatable, but not clinically evident in the new-born period. This is done to identify infants at risk for these conditions early enough to confirm the diagnosis and provide intervention that will alter the clinical course of the disease and prevent or ameliorate the clinical manifestations Squamous cell carcinoma.




  • Blood test


  • Genetic disorder screening



 


    Related Conference of New-Born Screening

    August 19-20, 2024

    25th Annual World Congress on Pediatrics

    Zurich, Switzerland
    September 05-06, 2024

    24th World Congress on Pediatric Neurology and Neuropathology

    Brussels, Belgium
    September 12-13, 2024

    28th World Nutrition and Pediatrics Healthcare Conference

    Paris, France
    September 19-20, 2024

    25th World Congress on Pediatric Oncology and Cancer Care

    Paris, France
    September 19-20, 2024

    3rd International Conference on Neonatology

    Paris, France
    September 26-27, 2024

    19th European Congress on Clinical Pediatrics and Child Care

    Budapest, Hungary
    October 21-22, 2024

    8th World Pediatrics Conference

    Tokyo, Japan
    November 27-28, 2024

    3rd World Congress on Pediatric Cardiology

    Amsterdam, Netherlands
    February 24-25, 2025

    24th Annual World Congress on Neonatology

    Toronto, Canada
    February 24-25, 2025

    34th World Congress on Clinical Pediatrics

    Toronto, Canada
    March 24-25, 2025

    39th Global Summit on Pediatrics

    London, UK
    May 15-16, 2025

    37th European Pediatrics Congress

    Paris, France
    May 26-27, 2025

    38th World Pediatrics Conference

    Rome, Italy

    New-Born Screening Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in